The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Wise Group plc (“Wise” or the “Company”) (NASDAQ: WSE) common stock between May 11, 2026 and July 23, 2026, inclusive (“the Class Period”).

If you suffered a loss on your Wise investments, you have until September 29, 2026 to request lead plaintiff appointment. Courts do not consider lead plaintiff applications submitted after this deadline. If you choose to take no action, you may remain an absent class member. For more information about the lawsuit:

[CONTACT THE FIRM IF YOU SUFFERED A LOSS]

What Is This Lawsuit About? The lawsuit alleges that Wise made materially false and/or misleading statements and failed to disclose that, in order to have a successful debut on the NASDAQ, the Company materially understated Wise’s regulatory risks as a result of its materially deficient anti-money laundering efforts and insufficient efforts to prevent the financing of terrorism.

On June 1, 2026, Reuters published an article entitled “Fintech Wise’s shares fall on Belgian money-laundering investigation.” The article reported that London-listed shares in Wise fell by more than 10% on the news that the Brussels Public Prosecutor’s Office was investigating the Company’s European entity in cases involving over $582.5 million in suspicious transactions. The article revealed that the investigation “concerns potential money laundering offences, with alleged links to fraud, corruption and drug trafficking” and “whether Wise Europe’s services were used by international criminal organizations.” On this news, Wise’s U.S. stock price fell $0.67 per share, or 5.24%, to close at $12.10 on June 1, 2026. The price then fell $0.56 per share, or 4.6%, to close at $12.10 on June 2, 2026. The stock fell a further $0.82 per share, or 7.1%, to close at $10.72 per share on June 3, 2026.

On July 24, 2026, The Wall Street Journal published an article entitled “Wise Group Shares Drop After U.S. Regulator Denies License on Shortcomings.” The article reported that London-listed shares in Wise fell after the Office of the Comptroller of the Currency denied the Company’s application for a national trust bank license, “citing deficiencies in its program to combat money laundering and terrorism financing.” On this news, Wise’s stock price fell $0.75 per share, or 6.2%, to close at $11.33 per share on July 24, 2026.

[LEARN MORE ABOUT THE LAWSUIT]

The Lead Plaintiff Appointment Process. The federal securities laws permit any investor who acquired eligible securities during the class period to seek appointment as lead plaintiff in a class action lawsuit. Learn more about the lead plaintiff process and eligibility requirements here. Courts typically appoint the investor(s) with the largest financial loss in the case and the ability to represent the class rather than investors with simply the largest investment portfolio. Courts regularly appoint individual investors, whether acting alone or as a group, as lead plaintiffs. The rights of any investor who bought shares during the class period are generally already protected. However, lead plaintiffs have the power to influence case strategy and have a say in settlement decisions, as well as decisions concerning allocation of settlement funds among class members.

[LEARN MORE ABOUT THE LEAD PLAINTIFF PROCESS]

What Should I Do? If you purchased or otherwise acquired Wise securities, have information, or would like to learn more about this investigation, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests with respect to these matters at no cost.

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260803832742/en/